UniProt P98162
Subgroup a rous sarcoma virus receptor PG950 (P98162)
Subgroup a rous sarcoma virus receptor PG950 (UniProt P98162): 4 experimental structures and 1 predicted model on GenesisL1. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- P98162
- Protein
- Subgroup a rous sarcoma virus receptor PG950
- Experimental structures
- 4
- Predicted models
- 1
Structures
5 records of P98162 in the MolNFT archive: 4 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1JRF | NMR Solution Structure of the Viral Receptor Domain of Tva | solution nmr | A | — | — |
| 1JRF | NMR solution structure of the viral receptor domain of tva | solution nmr | A | — | — |
| 1K7B | NMR Solution Structure of sTva47, the Viral-Binding Domain of Tva | solution nmr | A | — | — |
| 1K7B | NMR solution structure of STVA47, the viral-binding domain of tva | solution nmr | A | — | — |
| P98162 | AlphaFold monomer V2.0 prediction for subgroup a rous sarcoma virus receptor PG950 (P98162) | predicted | A | — | — |
Experiment against prediction
- 1K7B chain A against the predicted model P98162: TM-score 0.72, RMSD 1.90 Å
- 1K7B chain A against the predicted model P98162: TM-score 0.72, RMSD 1.90 Å
- 1JRF chain A against the predicted model P98162: TM-score 0.42, RMSD 2.88 Å
- 1JRF chain A against the predicted model P98162: TM-score 0.42, RMSD 2.88 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.